International journal of molecular sciences
Cure8 research brief
Why This Matters
This study explores a potential mechanism linking a MAP infection model to inflammatory and metabolic pathways relevant to Crohn’s disease and tests whether methylglyoxal can lessen inflammatory programming in macrophages. It may point to new research avenues, but it is not clinical evidence for treatment.
Who Should Pay Attention
Researchers (MAP, IBD, immune-metabolism), translational scientists, clinicians interested in IBD pathogenesis, informed patients curious about lab research.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This laboratory study (abstract-level summary) tested whether low-dose methylglyoxal (MGO), a component abundant in manuka honey and also produced inside cells, changes inflammatory and metabolic signaling in human THP-1 macrophages infected with Mycobacterium avium subspecies paratuberculosis (MAP), a microorganism linked in some research to Crohn’s disease.
The authors report that MGO reduced several pro-inflammatory markers and altered markers tied to glycolysis, lactate export (MCT4), and antioxidant (Nrf2/HO-1) responses in the infected macrophages. The work is preclinical/basic science using an in vitro macrophage infection model, not a clinical trial or treatment study.
The findings describe changes in gene/protein markers and propose molecular mechanisms; they do not provide evidence that MGO or manuka honey is safe or effective as a therapy for people with Crohn’s disease.
Keep In Mind
Findings are from an in vitro macrophage infection model (abstract-level summary). The paper proposes molecular mechanisms and marker changes but does not include human or animal efficacy/safety data. Treat this as preclinical research.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInternational journal of molecular sciences
AuthorsAlrefaey HR, Naser SA
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedAug 2, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: Florida Legislative Grant - NA
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Responses of intestinal organoids to infection by resemble symptoms observed in Crohn's disease Mycobacterium avium .
The work models how Mycobacterium avium can provoke epithelial inflammation similar to Crohn's disease, pointing to possible molecular links between infection and CD-like pathology that could guide future research.
Crohn's Disease-associated variant in laccase domain containing 1 (LACC1) modulates T ... - Nature
The paper links a Crohn’s disease GWAS signal to reduced LACC1 expression in lymphocytes and to altered immunometabolic function, clarifying a potential mechanism by which genetic variation contributes to IBD risk. It...
Sutterella Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation byspecies.
Researchers identify a gut microbe (Sutterella species) that may worsen intestinal inflammation by blocking AhR-driven IL-22 and IL-17 responses—pathways that help protect the gut lining.